ADAP
Adaptimmune Therapeutics
ADAP
ADAP
49 hedge funds and large institutions have $103M invested in Adaptimmune Therapeutics in 2019 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 12 increasing their positions, 14 reducing their positions, and 12 closing their positions.
Holders
49
Holders Change
-10
Holders Change %
-16.95%
% of All Funds
1.08%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
2
Increased
12
Reduced
14
Closed
12
Calls
$29K
Puts
–
Net Calls
+$29K
Net Calls Change
-$56K
Top Buyers
1 |
1
Renaissance Technologies
New York
|
$1.33M |
2 |
2
Morgan Stanley
New York
|
$609K |
3 |
3
Man Group
London,
United Kingdom
|
$3.1M |
4 |
4
Wellington Management Group
Boston,
Massachusetts
|
$2.41M |
5 |
![]()
5
Marshall Wace
London,
United Kingdom
|
$120K |